Meta description: AI dental imaging tools like Pearl, Overjet, and Diagnocat are changing how dentists read radiographs and present findings. A clinician's practical guide to what's real, what's hype, and what to implement first.
Dental imaging is where artificial intelligence first proved its worth in clinical dentistry, and where the technology has advanced furthest in proven clinical utility. But "AI in dental imaging" has become a term that covers everything from sophisticated FDA-cleared diagnostic software to marketing claims on basic image enhancement features—and that range makes it hard to know what's actually worth your attention.
This guide is for the practicing dentist who wants to understand what AI imaging tools genuinely do, how to read the clinical evidence, and how to make a rational implementation decision. No hype. No vague promises. Specifics.
Is AI worth it for your practice? Run the numbers.
Our free Dental AI ROI Calculator helps you estimate payback period, monthly revenue lift, and break-even point based on your practice's actual numbers — takes 2 minutes.
The Foundation: What These Tools Are Analyzing
Modern AI dental imaging tools are trained on annotated radiograph datasets—collections of X-rays where experienced clinicians have labeled specific findings (caries, bone levels, calculus, periapical lesions, root morphology). The AI learns to detect similar patterns in new images.
The key distinction is between detection (flagging that something is present) and diagnosis (interpreting what it means clinically). Current AI tools do the former well. The latter remains your responsibility—and that's appropriate. AI should augment clinical judgment, not replace it.
Most tools operate on three imaging modalities:
2D Periapical and Bitewing Radiographs — The most mature application. Tools here are FDA-cleared for specific indications and have the strongest published clinical evidence.
Panoramic Radiographs — Growing application area. AI tools can screen panoramics for pathology, measure bone levels, and flag anatomical anomalies with reasonable reliability.
CBCT (3D Imaging) — The frontier. Rapidly developing but still less mature than 2D applications. Most useful for implant planning, airway analysis, and complex case assessment.
The Major Players: What Each Does Best
Pearl (Second Opinion)
Pearl's FDA-cleared Second Opinion product integrates with your existing imaging software—it's compatible with Dexis, Dentsply Sirona, Carestream, Planmeca, and others—and overlays findings on your radiographs in real time as images are captured or reviewed.
Pearl excels at:
- Caries detection across all surfaces on bitewings and PAs
- Bone level measurement from the CEJ with sub-millimeter precision
- Calculus identification on periapicals and bitewings
- Periapical pathology flagging on PAs
Pearl's notable differentiator is its insurance documentation support. The system generates structured finding reports that support pre-authorization documentation—a practical benefit that goes beyond clinical detection.
Overjet
Overjet is the other major FDA-cleared player with strong published evidence. It's particularly strong in multi-location and DSO environments because of its reporting and quality assurance capabilities across provider groups.
Overjet distinguishes itself with:
- Bone level analytics with tracking over time across multiple radiographs
- Provider comparison reporting (useful for group practices identifying training needs)
- Insurance pre-authorization support with structured documentation
- Patient-facing visualizations optimized for case presentation
Overjet has integrations with Eaglesoft, Dentrix, and several DSO-specific PMS systems, and has completed CE Mark approval in Europe in addition to FDA clearance.
Diagnocat
Diagnocat focuses primarily on CBCT and panoramic analysis, which differentiates it from Pearl and Overjet's 2D focus. It's particularly useful for practices doing a significant volume of CBCT imaging.
Diagnocat capabilities include:
- Full-arch CBCT segmentation with tooth-by-tooth analysis
- Airway analysis for dental sleep medicine screening
- Implant planning support with bone density mapping
- Pathology screening on panoramics
If your practice does significant implant placement, full-arch restorative work, or sleep medicine, Diagnocat's 3D capabilities are worth evaluating seriously.
Videa AI
Videa is a newer entrant with some interesting clinical research, particularly around their ensemble approach—using multiple neural networks to cross-validate findings rather than relying on a single model. Their published sensitivity/specificity data is competitive with Pearl and Overjet.
Videa's integration pathway is slightly more limited, which is worth checking against your imaging setup before committing.
Reading the Clinical Evidence: What to Trust
The peer-reviewed literature on AI dental diagnostics has grown substantially in the last three years. Key things to know when evaluating studies:
Sensitivity vs. Specificity trade-offs matter. A tool with 90% sensitivity and 70% specificity will flag more true positives but also more false positives. Depending on your practice philosophy and patient population, you may prioritize one over the other. Ask vendors for both numbers.
Controlled study performance vs. real-world performance differ. Clinical trials use standardized image quality and experienced clinician labeling as ground truth. Real-world performance is typically somewhat lower because image quality varies and clinical presentations are messier. Be skeptical of vendors who cite only their best controlled-study numbers.
Ex vivo vs. in vivo studies. Studies using extracted teeth with known lesion sizes are more controlled but less representative of clinical reality than studies using clinical radiographs with clinical follow-up as the outcome measure. Both are useful; the latter is more applicable.
Independent validation matters. Research funded by the AI vendor should be read with appropriate skepticism. Independent replication is more meaningful. The literature is becoming more independent as academic dental programs run their own evaluations.
A 2022 systematic review in Journal of Dentistry covering 37 studies of AI caries detection found pooled sensitivity of 0.83 and specificity of 0.80—competitive with experienced clinicians under similar conditions. More recent studies with improved networks are reporting higher numbers.
The Patient Communication Case for AI Imaging
One of the most underappreciated benefits of AI imaging tools is what happens in the patient conversation—not in detection, but in presentation.
When you can show a patient their bitewing with AI-generated colored overlays marking suspected pathology, with confidence scores and measurements, you've given them something tangible. You're no longer asking them to trust your interpretation of an image they can't read. You have a visual, seemingly objective third party saying "this area needs attention."
Practices that have implemented these tools consistently report improvements in case acceptance for restorative dentistry. The mechanism is straightforward: patients who can see the problem in a format that's visually compelling to them are more likely to accept treatment than patients who are told there's a problem.
This doesn't mean using AI findings to oversell treatment. It means that legitimate clinical findings have better follow-through when they're communicated visually.
Integration: The Part Nobody Talks About Enough
The most common implementation headache with AI imaging tools isn't the AI—it's the integration. Your imaging workflow likely involves several systems: your imaging sensor or CBCT unit, your imaging software (bridge software or dedicated viewer), and your practice management software. AI tools need to fit into this chain cleanly.
Key integration questions:
- Does the AI tool integrate with my specific imaging software version? Not just the software brand, but the specific version you're running. Some integrations break on software updates.
- Is it a server-side or cloud-based analysis? Server-side keeps data on premises; cloud-based typically offers faster development cycles and cross-device access. Each has security and workflow implications.
- How does the AI display findings? Overlay on my existing viewer, separate screen, or in a patient-facing app? The display location affects workflow integration.
- Can findings be saved to the patient record in my PMS? Or does documentation require manual entry?
Run a real integration test before committing. Ask the vendor to complete a demo using your actual imaging software and your actual PMS. Not a scripted demo environment—your actual setup.
Regulatory Reality: FDA Clearance and What It Means
Pearl and Overjet are FDA-cleared for caries detection in bitewing radiographs. FDA clearance means the device has been reviewed through the 510(k) pathway and found to be substantially equivalent to a predicate device in terms of safety and effectiveness.
It does not mean the device is approved as a replacement for your clinical judgment. It means it's cleared as an adjunctive diagnostic aid—and that's how it should be used.
Some tools on the market make AI-powered claims without FDA clearance for specific diagnostic functions. This doesn't mean they're ineffective, but it means you're using them without regulatory validation for those specific claims. Know the difference.
For CBCT applications, the regulatory landscape is more complex, and you should review each specific claimed use of any CBCT AI tool against its clearance status.
Implementation: Getting Adoption Right
The technology decision is often easier than the adoption challenge. Here's what separates practices that get value from AI imaging from those who install it and forget about it:
Protocol, not option. If AI review is optional—if the clinician can choose to proceed without AI analysis—adoption will be inconsistent and the value will be undermined. Build it into your clinical workflow as a standard step for specified imaging types.
Train on the exceptions, not just the successes. Show your team cases where the AI flagged something that wasn't clinically significant (false positives). This builds appropriate calibration—staff learn to treat AI findings as hypotheses to evaluate, not verdicts to accept uncritically.
Review your early findings as a team. Monthly case reviews where you look at AI-flagged findings and clinical outcomes build collective calibration and catch any systematic issues with your workflow early.
Track your metrics. What was your case acceptance rate for restorative treatment before and after? What's your patient feedback on the visual presentation? What's your staff's subjective experience of using it? These aren't just business metrics—they're quality improvement data.
The Bottom Line
AI dental imaging is the most clinically mature AI application in dentistry. The evidence is real, the FDA clearances are real, and the clinical and business benefits are documented by practices across the country.
The right tool depends on your imaging modalities, your PMS/imaging software environment, your practice focus (general dentistry, implants, perio, sleep medicine), and your appetite for change management. The wrong approach is buying based on a polished demo without running a real integration test and a rigorous pilot.
The opportunity is genuine. Approach it like a clinical decision—with evidence, skepticism, and clear outcome metrics.
Practice Edge covers AI tools and workflows for modern dental practices. Subscribe for weekly articles on technology, practice management, and clinical efficiency.